Statistics Canada
www.statcan.gc.ca
Common menu bar links
Table 3
Age-specific, five-year prevalence proportions (per 100,000) for all cancers combined, by sex, Canada, January 1, 2005
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
| Cancer | Age group | ||||||
|---|---|---|---|---|---|---|---|
| All ages | 20 to 39 | 40 to 49 | 50 to 59 | 60 to 69 | 70 to 79 | 80 or older | |
| Males | |||||||
| All cancers | 1,433.7 | 183.8 | 486.0 | 1,656.3 | 4,898.2 | 8,287.8 | 8,945.3 |
| Oral cavity and pharynx† | 45.4 | 5.4 | 34.2 | 88.6 | 147.3 | 180.1 | 186.6 |
| Esophagus† | 8.3 | 0.3 | 2.6 | 11.4 | 32.6 | 47.1 | 42.5 |
| Stomach† | 19.2 | 1.1 | 7.7 | 23.6 | 60.5 | 113.9 | 137.9 |
| Colorectal† | 205.6 | 8.3 | 55.5 | 236.0 | 679.3 | 1,268.0 | 1,589.9 |
| Colon excluding rectum† | 126.0 | 5.1 | 30.9 | 129.3 | 397.0 | 801.1 | 1,091.8 |
| Rectum and rectosigmoid† | 79.5 | 3.2 | 24.6 | 106.7 | 282.2 | 467.0 | 498.2 |
| Anus† | 4.6 | 0.5 | 3.3 | 7.4 | 16.0 | 20.0 | 23.1 |
| Liver† | 7.4 | 0.7 | 3.7 | 13.8 | 25.5 | 33.7 | 24.6 |
| Pancreas† | 7.5 | 0.6 | 4.2 | 12.1 | 27.9 | 33.6 | 39.4 |
| Larynx† | 20.2 | 0.4 | 5.9 | 28.7 | 83.1 | 114.8 | 94.6 |
| Lung and bronchus† | 88.7 | 2.0 | 19.3 | 97.4 | 324.9 | 596.1 | 543.3 |
| Soft tissue† | 10.3 | 5.0 | 9.3 | 13.6 | 20.4 | 37.0 | 45.9 |
| Skin melanoma† | 56.3 | 17.5 | 47.7 | 94.4 | 145.4 | 225.8 | 269.3 |
| Prostate† | 539.7 | 0.3 | 31.6 | 500.1 | 2,222.2 | 3,727.0 | 3,512.4 |
| Testis‡ | 24.0 | 48.3 | 38.0 | 15.2 | 8.3 | 4.3 | 6.7 |
| Bladder (including in situ† | 103.3 | 3.2 | 22.2 | 99.9 | 311.8 | 673.0 | 970.4 |
| Kidney and renal pelvis† | 48.2 | 4.8 | 31.0 | 84.1 | 158.9 | 219.3 | 209.4 |
| Brain | 13.7 | 11.1 | 16.3 | 17.6 | 20.6 | 18.2 | 15.0 |
| Thyroid† | 17.6 | 12.6 | 23.7 | 32.5 | 35.5 | 37.6 | 25.1 |
| Hodgkin lymphoma‡ | 13.1 | 19.6 | 14.9 | 11.4 | 13.9 | 14.1 | 9.3 |
| Non-Hodgkin lymphoma† | 62.9 | 15.6 | 46.9 | 98.9 | 183.9 | 265.0 | 272.4 |
| Multiple myeloma† | 15.2 | 0.7 | 6.4 | 21.8 | 51.2 | 81.3 | 103.9 |
| Leukemias† | 42.2 | 10.2 | 20.7 | 51.3 | 111.9 | 176.1 | 243.1 |
| Other, unknown† | 76.7 | 15.5 | 39.4 | 91.9 | 205.4 | 380.9 | 547.7 |
| Females | |||||||
| All cancers | 1,391.6 | 293.8 | 1,067.8 | 2,229.0 | 3,643.7 | 4,742.7 | 4,934.9 |
| Oral cavity and pharynx† | 22.1 | 4.8 | 17.3 | 33.5 | 53.6 | 78.0 | 85.9 |
| Stomach† | 10.7 | 1.0 | 4.9 | 11.4 | 24.2 | 47.5 | 68.3 |
| Colorectal† | 172.3 | 7.8 | 52.8 | 176.2 | 424.9 | 812.6 | 1,143.3 |
| Colon excluding rectum† | 122.8 | 5.2 | 32.8 | 114.9 | 290.0 | 592.4 | 873.4 |
| Rectum and rectosigmoid† | 49.5 | 2.6 | 20.1 | 61.2 | 134.9 | 220.2 | 269.9 |
| Anus† | 6.2 | 0.3 | 5.4 | 11.1 | 15.5 | 20.1 | 26.7 |
| Pancreas† | 7.7 | 0.7 | 3.6 | 9.4 | 21.9 | 33.0 | 37.7 |
| Lung and bronchus† | 83.3 | 2.6 | 35.3 | 116.6 | 282.9 | 398.9 | 270.7 |
| Soft tissue† | 8.4 | 4.8 | 7.8 | 10.0 | 15.5 | 19.8 | 26.8 |
| Skin melanoma† | 52.4 | 29.3 | 61.7 | 86.0 | 96.5 | 127.8 | 140.7 |
| Breast† | 529.7 | 59.3 | 477.9 | 1,033.4 | 1,473.9 | 1,638.6 | 1,568.0 |
| Cervix uteri | 33.5 | 32.3 | 61.2 | 49.9 | 45.6 | 40.4 | 34.5 |
| Corpus uteri† | 94.7 | 5.7 | 42.3 | 183.6 | 344.6 | 336.0 | 258.0 |
| Ovary† | 38.6 | 10.5 | 36.7 | 77.2 | 105.3 | 109.3 | 72.8 |
| Bladder (including in situ)† | 33.5 | 1.7 | 8.6 | 34.9 | 86.9 | 159.1 | 215.0 |
| Kidney and renal pelvis† | 31.8 | 4.5 | 20.6 | 46.7 | 87.0 | 127.6 | 108.0 |
| Brain | 10.3 | 9.1 | 11.6 | 12.5 | 14.7 | 12.3 | 6.2 |
| Thyroid | 63.4 | 64.2 | 105.6 | 103.8 | 93.3 | 68.0 | 39.7 |
| Hodgkin lymphoma‡ | 10.3 | 18.4 | 8.7 | 8.2 | 7.4 | 10.9 | 7.2 |
| Non-Hodgkin lymphoma† | 55.3 | 12.4 | 35.4 | 76.3 | 152.4 | 211.2 | 206.4 |
| Multiple myeloma† | 13.2 | 0.5 | 4.5 | 15.7 | 36.1 | 62.8 | 71.5 |
| Leukemias† | 29.5 | 7.4 | 15.8 | 29.0 | 58.4 | 105.5 | 136.5 |
| Other, unknown† | 75.4 | 16.0 | 47.4 | 91.2 | 174.2 | 279.1 | 373.1 |
| † statistically significant increasing trend in prevalence proportions across age groups ‡ statistically significant decreasing trend in prevalence proportions across age groups Note: Prevalence proportions were determined by a tumour-based analysis. Source: Canadian Cancer Registry, Statistics Canada and Provincial/Territorial Cancer Registries. Table source: Statistics Canada, 2009, " Cancer prevalence in the Canadian population", Health Reports, Vol. 20, No. 1, catalogue number 82-003-X. |
|||||||
